loadpatents
name:-0.037807941436768
name:-0.028861045837402
name:-0.0030109882354736
Hewawasam; Piyasena Patent Filings

Hewawasam; Piyasena

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hewawasam; Piyasena.The latest application filed is for "hepatitis c virus inhibitors".

Company Profile
2.53.62
  • Hewawasam; Piyasena - Middletown CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds useful as immunomodulators
Grant 10,745,382 - Yeung , et al. A
2020-08-18
Hepatitis C virus inhibitors
Grant 10,617,675 - Frennesson , et al.
2020-04-14
Compounds useful as immunomodulators
Grant 10,144,706 - Yeung , et al. De
2018-12-04
Hepatitis C Virus Inhibitors
App 20180221342 - Frennesson; David B. ;   et al.
2018-08-09
Compounds Useful As Immunomodulators
App 20180057455 - YEUNG; KAP-SUN ;   et al.
2018-03-01
Compounds useful as immunomodulators
Grant 9,850,225 - Chupak , et al. December 26, 2
2017-12-26
Hepatitis C Virus Inhibitor
App 20170355689 - LAVOIE; RICO ;   et al.
2017-12-14
Hepatitis C virus inhibitors
Grant 9,776,981 - Lavoie , et al. October 3, 2
2017-10-03
Hepatitis C virus inhibitors
Grant 9,770,439 - Hewawasam , et al. September 26, 2
2017-09-26
Compounds Useful As Immunomodulators
App 20170107202 - YEUNG; KAP-SUN ;   et al.
2017-04-20
Hepatitis C Virus Inhibitors
App 20160199355 - HEWAWASAM; PIYASENA ;   et al.
2016-07-14
Combinations of Hepatitis C Virus Inhibitors
App 20160158200 - Hewawasam; Piyasena ;   et al.
2016-06-09
Hepatitis C virus inhibitors
Grant 9,326,973 - Hewawasam , et al. May 3, 2
2016-05-03
Hepatitis C Virus Inhibitors
App 20150322048 - Lavoie; Rico ;   et al.
2015-11-12
Hepatitis C Virus Inhibitors
App 20150297568 - Hewawasam; Piyasena ;   et al.
2015-10-22
Compounds Useful as Immunomodulators
App 20150291549 - Chupak; Louis S. ;   et al.
2015-10-15
Hepatitis C Virus Inhibitors
App 20150197499 - Lavoie; Rico ;   et al.
2015-07-16
Hepatitis C Virus Inhibitors
App 20150023913 - Hewawasam; Piyasena ;   et al.
2015-01-22
Hepatitis C virus inhibitors
Grant 8,796,466 - Bender , et al. August 5, 2
2014-08-05
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20140186299 - Bender; John A. ;   et al.
2014-07-03
Compounds for the treatment of hepatitis C
Grant 8,722,688 - Yeung , et al. May 13, 2
2014-05-13
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20140045816 - Bender; John A. ;   et al.
2014-02-13
Compounds for the treatment of hepatitis C
Grant 8,536,338 - Pracitto , et al. September 17, 2
2013-09-17
Compounds for the Treatment of Hepatitis C
App 20130197012 - Yeung; Kap-Sun ;   et al.
2013-08-01
Hepatitis C Virus Inhibitors
App 20130183269 - Hewawasam; Piyasena ;   et al.
2013-07-18
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20130171098 - Bender; John A. ;   et al.
2013-07-04
Hepatitis C Virus Inhibitors
App 20130115193 - Lavoie; Rico ;   et al.
2013-05-09
Hepatitis C virus inhibitors
Grant 8,377,980 - Belema , et al. February 19, 2
2013-02-19
Hepatitis C Virus Inhibitors
App 20120330019 - Wang; Xiangdong Alan ;   et al.
2012-12-27
Compounds for the Treatment of Hepatitis C
App 20120316126 - Yeung; Kap-Sun ;   et al.
2012-12-13
Compounds for the treatment of hepatitis C
Grant 8,309,558 - Yeung , et al. November 13, 2
2012-11-13
Compounds for the treatment of hepatitis C
Grant 8,293,909 - Pracitto , et al. October 23, 2
2012-10-23
Compounds for the Treatment of Hepatitis C
App 20120232099 - Pracitto; Richard ;   et al.
2012-09-13
Compounds For The Treatment Of Hepatitis C
App 20120201783 - Yeung; Kap-Sun ;   et al.
2012-08-09
Compounds for the treatment of hepatitis C
Grant 8,198,449 - Pracitto , et al. June 12, 2
2012-06-12
Compounds for the Treatment of Hepatitis C
App 20120115847 - Hewawasam; Piyasena ;   et al.
2012-05-10
Compounds for the treatment of hepatitis C
Grant 8,148,382 - Yeung , et al. April 3, 2
2012-04-03
Compounds for the treatment of Hepatitis C
Grant 8,129,367 - Hewawasam , et al. March 6, 2
2012-03-06
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20110311480 - Bender; John A. ;   et al.
2011-12-22
Hepatitis C Virus Inhibitors
App 20110286961 - Belema; Makonen ;   et al.
2011-11-24
Hepatitis C Virus Inhibitors
App 20110274648 - Lavoie; Rico ;   et al.
2011-11-10
Compounds for the treatment of hepatitis C
Grant 8,048,887 - Yeung , et al. November 1, 2
2011-11-01
Compounds for the Treatment of Hepatitis C
App 20110256099 - Yeung; Kap-Sun ;   et al.
2011-10-20
Hepatitis C Virus Inhibitors
App 20110237636 - Belema; Makonen ;   et al.
2011-09-29
Compounds for the treatment of hepatitis C
Grant 7,994,171 - Yeung , et al. August 9, 2
2011-08-09
Hepatitis C Virus Inhibitors
App 20110077280 - Bender; John A. ;   et al.
2011-03-31
Compounds for the Treatment of Hepatitis C
App 20100249094 - Yeung; Kap-Sun ;   et al.
2010-09-30
Compounds for the Treatment of Hepatitis C
App 20100184800 - Pracitto; Richard ;   et al.
2010-07-22
Compounds for the Treatment of Hepatitis C
App 20100093694 - Yeung; Kap-Sun ;   et al.
2010-04-15
Compounds for the Treatment of Hepatitis C
App 20100063068 - Pracitto; Richard ;   et al.
2010-03-11
Hepatitis C virus inhibitors
Grant 7,601,686 - Hewawasam , et al. October 13, 2
2009-10-13
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20090162318 - Bender; John A. ;   et al.
2009-06-25
Compounds for the treatment of Hepatitis C
Grant 7,547,690 - Gentles , et al. June 16, 2
2009-06-16
Compounds for the treatment of hepatitis C
Grant 7,541,353 - Gentles , et al. June 2, 2
2009-06-02
Compounds for the treatment of hepatitis C
Grant 7,538,103 - Hewawasam , et al. May 26, 2
2009-05-26
Compounds for the treatment of Hepatitis C
Grant 7,538,102 - Yeung , et al. May 26, 2
2009-05-26
Compounds for the Treatment of Hepatitis C
App 20090130057 - Hewawasam; Piyasena ;   et al.
2009-05-21
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,521,443 - Bender , et al. April 21, 2
2009-04-21
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,521,442 - Gentles , et al. April 21, 2
2009-04-21
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,521,441 - Gentles , et al. April 21, 2
2009-04-21
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,485,633 - Meanwell , et al. February 3, 2
2009-02-03
Indolobenzazepine HCV NS5B inhibitors
Grant 7,473,688 - Bergstrom , et al. January 6, 2
2009-01-06
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,456,166 - Bender , et al. November 25, 2
2008-11-25
Hepatitis C virus inhibitors
Grant 7,449,479 - Wang , et al. November 11, 2
2008-11-11
Compounds for the Treatment of Hepatitis C
App 20080226593 - Hewawasam; Piyasena ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080226591 - Gentles; Robert G. ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080227769 - Gentles; Robert G. ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080226592 - Yeung; Kap-Sun ;   et al.
2008-09-18
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,399,758 - Meanwell , et al. July 15, 2
2008-07-15
Cyclopropyl Fused Indolobenzazepine Hcv Ns5b Inhibitors
App 20080146537 - Bender; John A. ;   et al.
2008-06-19
Inhibitors of HCV replication
Grant 7,348,425 - Hudyma , et al. March 25, 2
2008-03-25
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20070275930 - Gentles; Robert G. ;   et al.
2007-11-29
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20070270405 - Bender; John A. ;   et al.
2007-11-22
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20070270406 - Gentles; Robert G. ;   et al.
2007-11-22
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20070184024 - Meanwell; Nicholas A. ;   et al.
2007-08-09
Indolobenzazepine HCV NS5B inhibitors
App 20070078122 - Bergstrom; Carl P. ;   et al.
2007-04-05
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
App 20070060565 - Meanwell; Nicholas A. ;   et al.
2007-03-15
3-thia-4-arylquinolin-2-one derivatives
Grant 7,179,920 - Boy , et al. February 20, 2
2007-02-20
N-substituted prodrugs of fluorooxindoles
Grant 7,169,803 - Starrett, Jr. , et al. January 30, 2
2007-01-30
Hepatitis C virus inhibitors
App 20070010455 - Hewawasam; Piyasena ;   et al.
2007-01-11
Inhibitors of HCV replication
Grant 7,153,848 - Hudyma , et al. December 26, 2
2006-12-26
Potassium channel modulators
Grant 7,151,180 - Hewawasam , et al. December 19, 2
2006-12-19
Hepatitis C virus inhibitors
Grant 7,132,504 - Scola , et al. November 7, 2
2006-11-07
Hepatitis C virus inhibitors
App 20060172950 - Wang; Xiangdong Alan ;   et al.
2006-08-03
Inhibitors of HCV replication
App 20060166964 - Hudyma; Thomas W. ;   et al.
2006-07-27
3-Thia-4-arylquinolin-2-one potassium channel modulators
Grant 7,049,309 - Boy , et al. May 23, 2
2006-05-23
Inhibitors of HCV replication
App 20060046983 - Hudyma; Thomas W. ;   et al.
2006-03-02
Hepatitis C virus inhibitors
Grant 6,995,174 - Wang , et al. February 7, 2
2006-02-07
N-substituted prodrugs of fluorooxindoles
App 20050203089 - Starrett, John E. JR. ;   et al.
2005-09-15
Hepatitis C virus inhibitors
App 20050187165 - Scola, Paul Michael ;   et al.
2005-08-25
3-Thia-4-arylquinolin-2-one potassium channel modulators
App 20050176763 - Boy, Kenneth M. ;   et al.
2005-08-11
Potassium channel modulators
App 20050080082 - Hewawasam, Piyasena ;   et al.
2005-04-14
3-thia-4-arylquinolin-2-one derivatives
App 20050080105 - Boy, Kenneth M. ;   et al.
2005-04-14
Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
App 20050043293 - Gribkoff, Valentin K. ;   et al.
2005-02-24
3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
Grant 6,855,829 - Dworetzky , et al. February 15, 2
2005-02-15
Cinnamide derivatives as KCNQ potassium channel modulators
Grant 6,831,080 - Wu , et al. December 14, 2
2004-12-14
Hepatitis C virus inhibitors
App 20040106559 - Wang, Xiangdong Alan ;   et al.
2004-06-03
Cinnamide derivatives as KCNQ potassium channel modulators
App 20030166650 - Wu, Yong-Jin ;   et al.
2003-09-04
Thiophenyl triazol-3-one derivatives as smooth muscle relaxants
Grant 6,613,786 - Hewawasam , et al. September 2, 2
2003-09-02
Thiophenyl triazol-3-one derivatives as smooth muscle relaxants
App 20030144333 - Hewawasam, Piyasena ;   et al.
2003-07-31
2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators
App 20020183335 - Hewawasam, Piyasena ;   et al.
2002-12-05
Fluoro oxindole derivatives as modulators of KCNQ potassium channels
App 20020156120 - Hewawasam, Piyasena ;   et al.
2002-10-24
Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases
App 20020128277 - Dworetzky, Steven I. ;   et al.
2002-09-12
Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
App 20020045566 - Gribkoff, Valentin K. ;   et al.
2002-04-18
Diphenyl imidazoles as potassium channel modulators
Grant 6,271,249 - Romine , et al. August 7, 2
2001-08-07
3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
Grant 6,184,231 - Hewawasam , et al. February 6, 2
2001-02-06
Diphenyl triazoles as potassium channel modulators
Grant 6,077,861 - Romine , et al. June 20, 2
2000-06-20
Phosphate derivatives of diaryl 1,3,4-oxadiazolone
Grant 5,939,405 - Starrett, Jr. , et al. August 17, 1
1999-08-17
Diphenyl oxadiazolones as potassium channel modulators
Grant 5,869,509 - Romine , et al. February 9, 1
1999-02-09
3-substituted oxindole derivatives as potassium channel modulators
Grant 5,602,169 - Hewawasam , et al. February 11, 1
1997-02-11
3-substituted oxindole derivatives as potassium channel modulators
Grant 5,565,483 - Hewawasam , et al. October 15, 1
1996-10-15
7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
Grant 5,208,237 - Hewawasam , et al. May 4, 1
1993-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed